A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.


Updates from The Motley Fool

Latest updates on Threshold Pharmaceuticals from Fool.com.


Stock Performance

THLD vs. S&P 500 | 2 Year Performance
View Interactive THLD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Threshold Pharmaceuticals.
Current Price: $0.90
Prev Close: $0.90
Open: $0.90
Bid: $0.85
Ask: $0.94
Day's Range: $0.88 - $0.93
52wk Range: $0.21 - $5.28
Volume: 978,482
Avg Vol 3,240,107
Market Cap: $64.67M
P/E (ttm): 0.57
EPS (ttm): $1.57
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Threshold Pharmaceuticals.
CAPS Rating 3 out of 5
 
113 Outperform
20 Underperform
CAPS All Stars
 
21 Outperform
5 Underperform

How do you think Threshold Pharmaceuticals will perform against the market?



You pick for Threshold Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Barry Selick, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Threshold Pharmaceuticals.

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers